6469.TWO
6469.TWO
TW0006469000
GREAT TREE PHARMACY CO LTD
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 60/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (-0.0x).

Beta (Market Relation)
-0x
Defensive
Volatility (5Y p.a.)
34.0% p.a.
5-Year Horizon
Max Drawdown (5Y)
-78.0%
5-Year Horizon
Sharpe Ratio
-0.29
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -44.2%
3 Years 29.1% -77.3% -1.39 -38.5%
5 Years 34.0% -78.0% -0.29 -7.5%
10 Years 32.6% -78.0% 0.43 +16.4%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (34.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -78.0% in the extended horizon.
ende